Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Clinical and immunological features of lacrimal gland enlargement in patients with thyroid eye disease
Author Affiliations & Notes
  • Pengxia Wan
    Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China
  • Yan Sun
    Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China
  • Fan Shi
    Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China
  • Congyao Wang
    Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China
  • Footnotes
    Commercial Relationships   Pengxia Wan None; Yan Sun None; Fan Shi None; Congyao Wang None
  • Footnotes
    Support  The Natural Science Foundation of Guangdong Province (2021A1515010372)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3048. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pengxia Wan, Yan Sun, Fan Shi, Congyao Wang; Clinical and immunological features of lacrimal gland enlargement in patients with thyroid eye disease. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3048.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Thyroid eye disease (TED) serves as the predominant extrathyroidal manifestation of Graves’disease (GD). Clinical studies have indicated a higher prevalence of lacrimal gland involvement in patients with TED than healthy controls. However, the etiology of lacrimal gland enlargement and the resulting ocular symptoms have not been evaluated comprehensively. This study aimed to investigate the clinical and immunological characteristics of lacrimal gland enlargement in patients with TED.

Methods : This retrospective study collected clinical data from patients who were initially diagnosed with TED at the First Affiliated Hospital, Sun Yat-sen University, between 2019 and 2023. TED patients were divided into two groups based on measurements of orbital magnetic resonance imaging (MRI): the enlarged lacrimal gland (ELG) and normal lacrimal gland (NLG) groups. Relevant ocular evaluations included clinical activity score (CAS), proptosis measurement, tear film break-up time (BUT), and Schirmer scores (Schirmer I). Immunological examinations included serum cytokines and lymphocyte subsets in peripheral blood. These data were comprehensively collected and analyzed.

Results : A total of 123 patients diagnosed with TED were included in this study, among whom bilateral lacrimal gland enlargement was observed in 87 patients. The ELG group had a younger age and a higher proportion of males compared to the NLG group. The presence of lacrimal gland enlargement in TED patients was associated with a higher likelihood of active TED (CAS≥3). Moreover, in comparison to the NLG group, patients with TED in the ELG group demonstrated a shorter BUT time, an elevated Schirmer score exceeding the upper limit of normal, and exacerbated exophthalmos. However, there was no difference in serum cytokines between the ELG and the NLG groups. In the ELG group, there was a significantly higher proportion of CD8+ T cells among subpopulations of lymphocytes compared to the NLG group. Further functional analysis of T lymphocytes demonstrated a decreased percentage of PD-1+ CD8+ T cells in the ELG group.

Conclusions : Lacrimal gland enlargement in TED indicated active TED, dry eye, tearing, and worse exophthalmos. Our findings suggested that increased and activated CD8+ T cells were positively correlated with lacrimal gland enlargement in TED.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×